bf/NASDAQ:MBIO_icon.jpeg

NASDAQ:MBIO

Mustang Bio

  • Stock

1.11

+1.83%

−0.59

USD last updated 13/08 01:59:42

Last Close

1.70

12/08 22:22

Market Cap

15.08M

Beta: 1.86

Volume Today

129K

Avg: 49.10K

PE Ratio

−0.16

PFCF: −0.23

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -6-4-22017-12-312019-11-122021-11-122023-08-142024-08-12

    Revenue (Estimate*)

    -40K-20K20K40K60K2017-12-312019-11-122021-11-122023-08-142024-08-12

    *Estimate based on analyst consensus